E-Bikes Vroom Forward
Health Care: Drugs
Warner Chilcott PLC (WCRX: NASDAQ)
$20.61 1.01 | 5.15%
05/21/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 20.61 |
| 52 Week High | 20.64 |
| 52 Week Low | 10.85 |
| Avg. Daily Vol. (Mil) | 6.31 |
| Beta (3 year) | 1.37 |
| Share Related Items | |
| Mkt Cap (Mil) | 5,169.22 |
| Shares Out (Mil) | 250.81 |
| Float (Mil) | 245.65 |
| Dividend Information | |
| Yield % | 2.40 |
| Annual Dividend | 0.50 |
| Payout Ratio | 264.00 |
| Financial Strength | |
| Quick Ratio | 0.70 |
| Current Ratio | 1.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | 12.80 |
| Price/Sales | 2.11 |
| Price/Book | 0.00 |
| Price/Cash Flow | 5.40 |
| Per Share Data | |
| Earnings | 1.61 |
| Sales | 9.76 |
| Book Value | 0.00 |
| Cash Flow | 3.84 |
| Business Summary | |
|---|---|
| A pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. | |
| General Information | |
| Ardee Business Park
Unit 19 Ardee, Co. Louth, |
|
| www.warnerchilcott.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 2100 | |
| CEO: Roger M. Boissonneault | |
| Short Interest | |
| Current Month (Mil) | 2.31 |
| Previous Month (Mil) | 2.76 |
| Short Interest Ratio (Days) | 0.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | 10.30 |
| Return on Investments | 13.40 |
| Profitability | |
| Gross Margin | 90.70 |
| EBIT Margin | 29.80 |
| Profit Margin | 16.50 |
Portfolios with WCRX
- Portfolio NameUser Type
- UserAbsolute Fusion
- UserKJP Autumn Moonlight
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ProD.E. Shaw
- ProPrivate Capital Management
- UserStock Game
- ContributorRelative Strength Stocks 09...
- ContributorTop Stocks of the 10 Best M...
Latest WCRX Headlines from TheStreet
- The Deal: Actavis Extends Gains Following Warner Deal 05.21.13 | 03:05 pm
- Warner Chilcott Reaches New 52-Week High (WCRX) 05.21.13 | 02:05 pm
- Stocks Slip on Concerns Markets Overpriced 05.20.13 | 04:05 pm
- Ireland Welcomes Watson Pharmaceuticals, an American Success 05.20.13 | 02:05 pm
- Dow Dull Except for Deal Stocks
05.20.13 | 11:05 am - Warner Chilcott Rises On Unusually High Volume (WCRX) 05.20.13 | 10:05 am
- The Deal: Actavis Plays Hunter in $8.5 Billion Deal for Ireland's Warner Chilcott 05.20.13 | 10:05 am
- Futures Slip as Investors Seek Fed Clarity 05.20.13 | 09:05 am
- Announcement Under Irish Takeover Rules Revision To Relevant Securities In Issue 05.20.13 | 09:05 am
- Yahoo! Deal Kicks Off Fed Week 05.20.13 | 08:05 am
Press Releases for WCRX
- Actavis To Acquire Warner Chilcott To Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire 05.20.13 | 07:05 am
- Warner Chilcott Prices Secondary Equity Offering - PR Newswire 03.10.11 | 06:03 pm
- Warner Chilcott Announces Secondary Equity Offering - PR Newswire 03.08.11 | 05:03 pm
- Warner Chilcott To Present At The Goldman Sachs Leveraged Finance Healthcare Conference - PR Newswire 03.04.11 | 04:03 pm
- Warner Chilcott Seeks To Refinance Its Existing Credit Agreement - PR Newswire 03.02.11 | 05:03 pm
- Warner Chilcott To Present At The 2011 RBC Capital Markets' Healthcare Conference - PR Newswire 02.22.11 | 08:02 am
- Warner Chilcott To Present At The Citi 2011 Global Health Care Conference - PR Newswire 02.18.11 | 04:02 pm
- Warner Chilcott Announces Earnings Release Date And Conference Call For Fourth Quarter And Full Year 2010 Financial Results - PR Newswire 02.15.11 | 04:02 pm
- Warner Chilcott Announces 2011 Financial Guidance Conference Call - PR Newswire 01.27.11 | 08:01 am
- Warner Chilcott To Present At The 29th Annual J.P. Morgan Healthcare Conference - PR Newswire 01.04.11 | 09:01 am
Partner Headlines for WCRX
- UPDATE: Citigroup Initiates Warner Chilcott PLC with Neutral on Pending Activities Execution - Benzinga 04.05.13 | 09:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- Stocks Slip Into Red Zone; Wal-Mart Down In Heavy Trade - Investor's Business Daily 02.15.13 | 12:02 pm
- Warner Chilcott Tops, View Raised - Analyst Blog - Zacks 11.15.12 | 09:11 am
- Apricus, Takeda Ink Marketing Deal - Analyst Blog - NASDAQ 09.14.12 | 10:09 pm
- Apricus, Takeda Ink Marketing Deal - Analyst Blog - Zacks 09.14.12 | 06:09 pm
- Warner Chilcott Plc Enters Oversold Territory - Tale of the Tape - NASDAQ 09.14.12 | 04:09 pm
- Stocks On Track For Upbeat Open On ECB, Economic News - Investor's Business Daily 09.06.12 | 09:09 am
- Warner Chilcott Plc Enters Oversold Territory - Tale of the Tape - NASDAQ 09.04.12 | 03:09 pm
- UPDATE: Morgan Stanley Downgrades Warner Chilcott to Underweight - Benzinga 08.21.12 | 01:08 pm
